CurrentRheuma
Get Weekly

Rheumatology journalCurrentRheuma coverage

Lupus

What CurrentRheuma has captured from this journal. The coverage figures describe CurrentRheuma's coverage, not the journal's output. Figures as of 14 November 2026.

CurrentRheuma holds 555 Briefs from Lupus, most often cohort studies and cross-sectional studies.

Recent
25 Briefs
past 90 days
Archive
555 Briefs
research published from January 2023 to today
Editorial
–
no Weekly issue published yet

Topics

Evidence types

Shares are of the 555 Briefs CurrentRheuma has covered from Lupus, by primary topic and study type; a Brief without a primary topic is in no topic row.

Publication activity

Latest from Lupus

All coverage, newest first

  1. Lupus

    Eltrombopag in the treatment of immune thrombocytopenia secondary to SLE: A double-edged sword

    Cohort studyLupus & APS

  2. Lupus

    Catastrophic antiphospholipid syndrome after COVID-19 mRNA vaccination: A case report

    Research articleLupus & APS

  3. Lupus

    Patient selection for advanced B-cell-targeted therapy trials in systemic lupus erythematosus

    Cohort studyLupus & APS

  4. Lupus

    Articular involvement in antiphospholipid syndrome: Clinical, laboratory, and imaging characterization

    Cross-sectional studyLupus & APS

  5. Lupus

    Biopsychosocial factors associated with body image in Brazilian women with Systemic Lupus Erythematosus

    Cross-sectional studyLupus & APS

  6. Lupus

    Advanced practice nursing and nurse-led models in systemic lupus erythematosus: A patient organisation-informed narrative review

    Research articleLupus & APS

  7. Lupus

    Transcriptomic effects of hydroxychloroquine in CD4+ T cells from patients with systemic lupus erythematosus: An exploratory pilot study

    Secondary analysisLupus & APS

  8. Lupus

    Performance of the systemic lupus erythematosus disease activity score (SLE-DAS) in daily clinical practice: A prospective study of 125 patients in India

    Diagnostic or prognostic studyLupus & APS

  9. Lupus

    Macrophage activation syndrome is associated with high in-hospital mortality in patients with lupus

    Cohort studyLupus & APS

  10. Lupus

    Colchicine usage and recurrent pericarditis in patients with systemic lupus erythematosus

    Cohort studyLupus & APS

  11. Lupus

    Multimarker profiling of immune and vascular disregulation in antiphospholipid syndrome and systemic lupus erythematosus

    Cross-sectional studyLupus & APS

  12. Lupus

    High burden and unique pattern of cerebral small vessel disease in antiphospholipid syndrome: MRI subtypes and risk profile in a large cohort

    Cohort studyLupus & APS

  13. Lupus

    Association of serum levels of galectin-9 and IP-10 with disease activation in lupus nephritis

    Cross-sectional studyLupus & APS

  14. Lupus

    Burden of herpes zoster and recombinant zoster vaccine willingness in systemic lupus erythematosus: A single-center cohort study

    Cohort studyLupus & APS

  15. Lupus

    Lupus nephritis at systemic lupus erythematosus onset and kidney outcomes in a Latin American biopsy-proven cohort

    Cohort studyLupus & APS

  16. Lupus

    Global prevalence and associated factors of metabolic syndrome in patients with systemic lupus erythematosus: A systematic review and meta-analysis

    Meta-analysisLupus & APS

  17. Lupus

    Views on pregnancy and related concerns among women with systemic lupus erythematosus: A cross-sectional study

    Cross-sectional studyLupus & APS

  18. Lupus

    Clinical characteristics of patients with primary antiphospholipid syndrome and “single” antiphospholipid antibody: Retrospective results from the APS ACTION clinical database and repository (“registry”)

    Cohort studyLupus & APS

  19. Lupus

    A structured primary care–led triage and referral pathway for systemic lupus erythematosus: Operational criteria and referral outcomes from a real-world rheumatology practice

    Cohort studyLupus & APS

  20. Lupus

    Uncertainty in illness and psychological adjustment in patients with systemic lupus erythematosus

    Cross-sectional studyLupus & APS

  21. Lupus

    Clinical characteristics of patients with late-onset systemic lupus erythematosus with a disease onset of ≤ 3 months

    Cohort studyLupus & APS

  22. Lupus

    Association of neutrophil-to-lymphocyte ratio with disease activity in systemic lupus erythematosus: A meta-analysis

    Meta-analysisLupus & APS

  23. Lupus

    IFI44L promoter hypomethylation as an epigenetic biomarker of systemic lupus erythematosus: A systematic review and meta-analysis

    Meta-analysisLupus & APS

  24. Lupus

    Interstitial palladin is associated with tubulointerstitial chronicity and adverse outcomes in patients with lupus nephritis

    Cohort studyLupus & APS

  25. Lupus

    Psychometric validation and reliability of the Arabic version of the LupusQoL questionnaire (Ar-LupusQoL) in Egyptian patients with systemic lupus erythematosus

    Cross-sectional studyLupus & APS

  26. Lupus

    Gut microbiota dysbiosis and plasma lipidomic signatures in systemic lupus erythematosus

    Mechanistic studyLupus & APS

  27. Lupus

    Association between maternal autoimmune connective tissue disease and cardiac structure and function in the newborn

    Cohort studySjögren's & overlap

  28. Lupus

    Hematological involvement in juvenile-onset systemic lupus erythematosus: Clinical features and its impact on disease management

    Cohort studyPediatric

  29. Lupus

    Achievement of real-world adapted DORIS remission targets among patients with systemic lupus erythematosus initiating belimumab in the USA: A retrospective, observational, cohort study

    Cohort studyLupus & APS

  30. Lupus

    Stigma, discrimination-related events, and determinants among adult people living with systemic lupus erythematosus (SLE): Systematic review and indicator-level meta-analysis

    Meta-analysisLupus & APS

  31. Lupus

    Network meta-analysis of triple immunosuppressive therapies and standard of care for induction of remission of active lupus nephritis

    Meta-analysisLupus & APS

  32. Lupus

    Validation and prognostic utility of SLERPI in a single-centre retrospective Central European cohort

    Diagnostic or prognostic studyLupus & APS

  33. Lupus

    Clinical phenotypes and disease outcomes of patients with systemic lupus erythematosus meeting indication for primary aldosteronism testing

    Cohort studyLupus & APS

  34. Lupus

    Impact of parenting on patient-reported outcomes in female patients with systemic lupus erythematosus: A cross-sectional study of the LUNA registry

    Cross-sectional studyLupus & APS

  35. Lupus

    Persistence of antimalarial therapy and its effect on mortality in systemic lupus erythematosus: A population-based longitudinal multistate study

    Cohort studyLupus & APS

  36. Lupus

    Serum C-reactive protein levels can predict organ damage in patients with SLE with the lupus low disease activity state

    Cohort studyLupus & APS

  37. Lupus

    Association of galectin-3 in systemic lupus erythematosus: A systematic review and meta-analysis

    Meta-analysisLupus & APS

  38. Lupus

    Diagnosis to dialogue: Reproductive health conversations and guideline adherence in women with lupus

    Cross-sectional studyLupus & APS

  39. Lupus

    Anifrolumab induces a fast improvement in ultrasound-detected synovitis in systemic lupus erythematosus: Results from a 6-months follow-up ultrasound study

    Cohort studyLupus & APS

  40. Lupus

    Hydroxychloroquine-induced retinopathy in Puerto Ricans with systemic lupus erythematosus: Associated factors and early-onset risk

    Cohort studyLupus & APS

All 555 Briefs in ExploreShowing the 40 most recently published